Agilent Technologies (A) filed a Form 8-K with the US Securities and Exchange Commission on August 26, 2026. Subject of the filing: results for the period. The stock closed at $155.08, up 0.2% on the day, on $497m of turnover.
That leaves the price near the top of its twelve-month band of $110.24 to $159.00 — 92% of the way up it. The peak itself came 3 sessions ago on August 21, 2026, while the floor dates back to March 27, 2026, 108 sessions ago.
The stock is down 0.2% over five sessions, up 12.5% over a month, up 22.8% over the year. The week and the year point in opposite directions. It closed above its thirty-day average price by 8.2%.
Intraday the stock covered 1.9%, in line with its 2.6% thirty-session norm, so the move arrived without unusual swings. The close held 89% of the way up the day's range into the bell. It was the 2nd session running higher.
Worth $39bn, the company sits 32 of 128 by size within healthcare. The sector as a whole finished -0.9%, leaning the other way.
From an open of $152.45 the price ranged down to $152.44 and up to $155.42 before closing on $155.08. That is 40.7% above the year's $110.24 floor and 2.5% under its $159.00 ceiling.
Turnover of $497m compares with $315m on an average session for this stock. Against the year, today ranks between the +16.9% best and the -5.0% worst day.
Recent form leans positive: 17 of the last thirty sessions closed up against 12 down. Its strongest single day in the past year was +16.9% on May 28, 2026, its weakest -5.0% on April 23, 2026.
The nearest names by size in the same sector went the same way: Idexx Laboratories (IDXX) +0.6% and Revolution Medicines (RVMD) +1.9%. On money traded A placed 190th of 986 that session.
This text was generated automatically from the closing data. It contains no forecasts and no investment advice — only what the numbers say. Do your own research.